Based on ratings from 1 stock analysts, the Forian Inc. stock price is expected to increase by 148.76% in 12 months. This is calculated by using the average 12-month stock price forecast for Forian Inc.. The lowest target is $5 and the highest is $5. Please note analyst price targets are not guaranteed and could be missed completely.
About 1 Wall Street analysts have assignedFORA 1 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Forian Inc. to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on FORA. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of FORA.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Richard Baldry Roth MKM | Buy | $5 | Reiterates | Nov 14, 2024 |
Richard Baldry Roth MKM | Buy | $5 | Reiterates | Apr 4, 2024 |
Richard Baldry Roth MKM | Buy | $5 | Initiates | Dec 20, 2023 |
Eric Martinuzzi Lake Street | Buy | $5 | Maintains | Aug 11, 2023 |
Drew McReynolds RBC Capital | Outperform | $17 | Maintains | Nov 10, 2022 |
Eric Martinuzzi Lake Street | Buy | $9 | Initiates | Apr 8, 2022 |
When did it IPO
2020
Staff Count
36
Country
United States
Sector/Industry
Healthcare/Health Information Services
CEO
Mr. Max C. Wygod
Market Cap
$65.1M
In 2023, FORA generated $20.5M in revenue, which was a increase of 24.75% from the previous year. This can be seen as a signal that FORA's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - Forian Inc. (NASDAQ: FORA) will hold its Q3 2024 earnings conference call on November 13, 2024, at 4:30 PM ET, featuring CEO Max Wygod and CFO Michael Vesey.
Why It Matters - Forian Inc.'s Q3 2024 earnings call could reveal financial performance and strategic insights, impacting stock valuation and investor sentiment. Key executives' comments may influence market expectations.
Summary - Forian Inc. (Nasdaq: FORA) reported its quarterly results for Q3 2024, ending September 30. Further financial details were not provided in the excerpt.
Why It Matters - Forian Inc.'s quarterly results can influence investor sentiment, impacting stock performance and valuations within the data analytics sector, particularly in life sciences and healthcare.
Summary - VerticalScope Holdings Inc. (TSX: FORA; OTCQX: VFORF) reported strong Q3 results for the period ending September 30, 2024, with positive momentum heading into the year's strongest seasonal period.
Why It Matters - VerticalScope's strong Q3 results and positive outlook signal growth potential and seasonal momentum, which could enhance investor confidence and drive stock performance.
Summary - Forian Inc. (FORA) reported quarterly earnings of $0.03 per share, exceeding the Zacks Consensus Estimate of $0.01 and matching earnings from the previous year.
Why It Matters - Forian Inc.'s earnings beat expectations, indicating strong performance and potential growth, which can positively influence investor sentiment and stock price.
Summary - Forian Inc. (Nasdaq: FORA) executives Max Wygod and Mike Vesey will attend ROTH MKM's 13th annual Technology Event on November 19-20, 2024, in New York City.
Why It Matters - Forian Inc.'s participation in a prominent technology event signals potential growth opportunities and investor interest, impacting its stock performance and market perception.
Summary - Forian Inc. (Nasdaq: FORA) will release its Q3 2024 financial results on November 13, 2024, after market close, followed by a conference call at 4:30 p.m. ET.
Why It Matters - Forian Inc.'s upcoming Q3 financial results announcement may impact stock prices, reflecting company performance and market expectations in the healthcare data analytics sector.